Abstract
This chapter discusses the relationship between risk and innovation. This is done by first, providing the background to the establishment and then the evolution of the risk analysis framework and second, by discussing the international governance capacity of risk and biotechnology. The highlights the gaps in the international regulatory structure for products of biotechnology. Following this, the chapter provides a detailed assessment of the North American regulatory framework for genetically modified crops. This portion of the chapter identifies the government departments and agencies that are involved in the regulation framework and the Acts that govern their oversight role. The chapter concludes that science-based regulatory systems provide a consistent and transparent process for managing the commercialization of innovative crop research.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
BASF (2012) News release: BASF to concentrate plant biotechnology activities on main markets in North and South America. http://www.basf.com/group/pressrelease/P-12-109. Accessed 10 June 2013
Buckingham D, Phillips PWB (2001) Hot potato, hot potato: regulating products of biotechnology by the international community. J World Trade 35(1):1–31
Canadian Food Inspection Agency (2011a) Directive 94-08: assessment criteria for determining environmental safety of plants with novel traits. http://www.inspection.gc.ca/english/plaveg/bio/dir/dir9408e.shtml. Accessed 10 Dec 2011
Canadian Food Inspection Agency (2011b) Regulation of agricultural biotechnology in Canada: an educator’s resource. http://www.inspection.gc.ca/english/sci/biotech/gen/educ_postsece.shtml. Accessed 10 Dec 2011
Canadian Lung Association (2004) Resurgence: is TB a problem in Canada today? http://www.lung.ca/tb/tbtoday/resurgence. Accessed 10 June 2013
Codex Alimentarius Commission (2012) Principles for the risk analysis of foods derived from modern biotechnology
Food and Agriculture Organization (2012) FAO/WHO Codex training package: section four—scientific basis for Codex work. 4.1 Risk analysis in the framework of Codex. ftp://ftp.fao.org/es/esn/food/capacity_building/4_1.pdf. Accessed 10 June 2013
Food and Drug Administration (1997) Guidance on consultation procedures; foods derived from new plant varieties. http://vm.cfsan.fda.gov/~lrd/consulpr.html. Accessed 10 Dec 2011
Isaac GE (2002) Agricultural biotechnology and transatlantic trade: regulatory barriers to GM crops. CABI Publishing, Wallingford
Health Canada (2011a) Genetically modified (GM) foods and other novel foods. http://www.hc-sc.gc.ca/fn-an/gmf-agm/index_e.html. Accessed 10 Dec 2011
Health Canada (2011b) Environmental impact initiative. http://www.hc-sc.gc.ca/ewh-semt/contaminants/person/impact/about-impact/index_e.html. Accessed 10 Dec 2011
Health Canada (2011c) Guidelines for the safety assessment of novel foods. http://www.hc-sc.gc.ca/fn-an/legislation/guide-ld/nf-an/guidelines-lignesdirectrices_e.html. Accessed 10 Dec 2011
Jackson LA, Jansen M (2010) Risk assessment in the international food safety policy arena. Can the multilateral institutions encourage unbiased outcomes? Food Policy 35:538–547
James C (2011) Global status of commercialized biotech/GM crops: 2011. ISAAA Brief 43. http://www.isaaa.org/resources/publications/briefs/43/executivesummary/default.asp. Accessed 10 June 2013
Kinsella KG (1992) Changes in life expectancy 1900–1990. Am J Clin Nutr 55:1196–1202
Lammerding AM, Paoli GM (1998) Quantitative risk assessment: an emerging tool for emerging food borne pathogens. Emerg Infect Dis 3(4):483–487
McHughen A, Smyth S (2008) US regulatory system for genetically modified (GMO, rDNA or transgenic) crop cultivars. Plant Biotechnol J 6(1):2–12
National Academy of Sciences (2000) Genetically modified pest protected plants: science and regulation. National Academies Press, Washington, DC
National Academy of Sciences (2004) Biological confinement of genetically engineered organisms. National Academies Press, Washington, DC
National Research Council (1983) Risk assessment in the Federal Government: managing the process. National Academy Press, Washington, DC
Office of Science and Technology Policy (1986) Coordinated framework for regulation of biotechnology: announcement of policy and notice for public comment. Fed Regist 51(123):23302–23350
Phillips PWB, Smyth SJ, Kerr WA (eds) (2006) Governing risk in the 21st century: lessons from the world of biotechnology. Nova Science Publishers, Hauppauge
Powell D (2000) Risk based regulatory responses in global food trade: a case study of Guatemalan raspberry imports into the United States and Canada, 1996–1998. In: Doern GB, Reed T (eds) Risky business: Canada’s changing science-based policy and regulatory regime. University of Toronto Press, Toronto
Sandman PM (1994) Mass media and environmental risk: seven principles. Risk Health Saf Environ 5(3):1–7
Smyth S, McHughen A (2008) Regulating innovative crop technologies in Canada: the case of regulating genetically modified crops. Plant Biotechnol J 6(3):213–225
Smyth S, Phillips PWB, Kerr WA (2009) Global governance quandaries regarding transformative technologies for bioproducts, crops, and foods. J World Trade 43(6):1299–1323
Smyth SJ, Kerr WA, Phillips PWB (2011) Recent trends in the scientific basis of sanitary and phytosanitary trade rules and their potential impact on investment. J World Invest Trade 12(1):5–26
World Health Organization (2012) Global tuberculosis report 2012. www.who.int/tb/publications/global_report/gtbr12_main.pdf. Accessed 10 June 2013
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Smyth, S., Falck-Zepeda, J., Ludlow, K. (2014). The State of Science-Based Regulation and Genetically Modified Crops. In: Ludlow, K., Smyth, S., Falck-Zepeda, J. (eds) Socio-Economic Considerations in Biotechnology Regulation. Natural Resource Management and Policy, vol 37. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9440-9_2
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9440-9_2
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9439-3
Online ISBN: 978-1-4614-9440-9
eBook Packages: Business and EconomicsEconomics and Finance (R0)